LEAD BOLDLY

IN CANCER RESEARCH

LEAD BRAVELY

IN CANCER RESEARCH

LEAD FEARLESSLY

IN CANCER RESEARCH

WE ARE TME

NEWS

Rakesh Patel, MD

Rakesh Patel, MD

Dr. Patel graduated with honors in premedical studies from the University of Notre Dame, South Bend, Indiana, and received his medical degree from the Indiana University School of Medicine. He completed his residency at the University of Wisconsin-Madison. He joined the UW Radiation Oncology faculty and led the Breast cancer clinical and research program where he was the recipient of two Komen Foundation research grants for targeted breast radiation. Dr Patel has a special interest in targeted radiation therapy with brachytherapy and radiosurgery. He has published over 50 manuscripts and 100 meeting abstracts. He has given over 75 invited national & 28 international lectureships and visiting professorships on Targeted Radiation and 3D-HDR Brachytherapy around the world including China, Japan, Korea, Singapore, Australia, India, and multiple European countries. He was elected as the 2010 President of the American Brachytherapy Society and leads several patient and physician training initiatives. He moved to community practice in the Silicon Valley in 2008 and currently serves as the Director of Radiation Oncology at the Targeted Radiation Institutes for VMOC in Pleasanton and Los Gatos, California.

Breast brachytherapy and breast augmentation: breast conservation without capsular contracture. Patel et al - Sem Breast Diseases. 2007.

Friday, 01 April 2016 00:00

Targeted therapy in the treatment of brain metastases: improving the therapeutic ratio. Patel et al - Clin Cancer Research. 2007.

Friday, 01 April 2016 00:00

Lumpectomy and Partial Breast Irradiation as an alternative to mastectomy after prior breast irradiation. Patel et al - Sem Breast Diseases. 2007.

Friday, 01 April 2016 00:00

Innovative approaches to APBI. Patel et al- Sem Breast Diseases. 2007.

Friday, 01 April 2016 00:00

A dosimetric comparison of acclerated partial breast irradiation techniques: multi-catheter interstitial brachytherapy, 3D-CRT, and supine versus prone helical tomotherapy. Patel et al - Inter J Rad Oncol Biol Phys. 2007

Friday, 01 April 2016 00:00

The case for treating partial breast irradiation over 5 days. Patel R - Sem Breast Diseases. 2007.

Friday, 01 April 2016 00:00

Increased skin dose with the use of custom mattress for prone breast radiotherapy. Patel et al - Med Dosimetry. 2007.

Friday, 01 April 2016 00:00

Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors. Beitsch and Whitworth et al - Am J Surg. 2007.

Friday, 01 April 2016 00:00

Multicenter evaluation of a new ultrasound-guided biopsy device: improved ergonomics, sampling, and rebiopsy rates. Gittleman et al - Breast J. 2007 Jan.

Friday, 01 April 2016 00:00

Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. Beitsch and Whitworth - J Clin Oncol. 2007 Aug.

Friday, 01 April 2016 00:00

Three-year treatment efficacy by the American Society of Breast Surgeons (ASBS) MammoSite Brachytherapy Registry Trial in patients treated with Accelerated Partial Breast Iradiation (APBI). Beitsch, Gittleman, and Whitworth - Int J Rad Onc. 2007 Oct.

Friday, 01 April 2016 00:00

Scientific Impact Recognition Award. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes convenional histologic sampling errors. Whitworth and Beitsch et al - Am J Surg. 2007 Oct.

Friday, 01 April 2016 00:00

Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis. Beitsch et al - J Surg Research. 2007 Nov.

Friday, 01 April 2016 00:00

Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-year results. Patel et al - Inter J Rad Oncol Biol Phys. 2008.

Friday, 01 April 2016 00:00

The use of directional interstitial sources to improve dosimetry in breast brachytherapy. Patel et al - Med Physics. 2008.

Friday, 01 April 2016 00:00

Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Beitsch and Gittleman. 2008

Friday, 01 April 2016 00:00

Clinical outcome analysis in “high-risk” versus “low-risk” patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results. Patel et al - Inter J Rad Oncol Biol Phys. 2008.

Friday, 01 April 2016 00:00

Cosmesis and radiation toxicity following baloon brachytherapy in early breast cancer: Preliminary 5-year results. Gittleman et al - Society of Surg Oncol. 2008 Mar.

Friday, 01 April 2016 00:00

Assessment of intraoperative margin status using a novel device measuring surface cellular electromagnetic properties. Gittleman et al - Society Surg Oncol. 2008 Mar.

Friday, 01 April 2016 00:00

Is there an optimal skin to catheter distance for balloon brachytherapy in breast cancer? Experience over 5 years. Gittleman et al - Society Surg Oncol. 2008 Mar.

Friday, 01 April 2016 00:00

Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. Whitworth and Beitsch - J Clin Oncol. 2008 Jul.

Friday, 01 April 2016 00:00

Effect of multiple nodal basin drainage on cutaneous melanoma. Beitsch et al - Archives of Surgery. 2008 Jul.

Friday, 01 April 2016 00:00

Impact of immediate vs delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 + Z0011. Beitsch Whitworth- J Clin Onc. 2008.

Friday, 01 April 2016 00:00

Getting to Better Care Results of a Society of Surgical Oncology Survey. Beitsch et al - Ann Surg Oncol. 2008 Sept.

Friday, 01 April 2016 00:00

Multicatheter hybrid breast brachytherapy: a potential alternative for patients with inadequate skin distance. Patel et al - Brachytherapy. 2008 Oct.

Friday, 01 April 2016 00:00

Recommendations for permanent prostate brachytherapy with (131)Cs: a consensus report from the Cesium Advisory Group. Patel et al - Brachytherapy. 2008 Oct.

Friday, 01 April 2016 00:00

Timing of Chemotherapy after MammoSite radiation therapy system breast brachytherapy: analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Beitsch, Gittleman, and Whitworth - Int J Radiat Oncol Biol 2008

Friday, 01 April 2016 00:00

The surgeon’s role in breast brachytherapy. Beitsch, Gittleman, Patel, and Whitworth et al - Breast J. 2009 Jan.

Friday, 01 April 2016 00:00

A dosimetric comparison of MammoSite and ClearPath high-dose-rate breast brachytherapy devices. Patel et al - Brachytherapy. 2009 Jan.

Friday, 01 April 2016 00:00

AIUM practice guideline for the performance of a breast ultrasound examination. Gittleman et al - J Ultrasound Med. 2009 Jan.

Friday, 01 April 2016 00:00

Breast brachytherapy devices. Patel et al - Expert Rev Med Devices. 2009 May.

Friday, 01 April 2016 00:00

Local control, toxicity, and cosmesis in women younger than 50 enrolled onto the American Society of Breast Surgeons Mammosite Radiation Therapy System registry trial. Beitsch, Gittleman, and Whitworth et al - Ann Surg Oncol. 2009 Jun.

Friday, 01 April 2016 00:00

Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial. Beitsch, Gittleman, and Whitworth et al - Am J Surg. 2009 Jul.

Friday, 01 April 2016 00:00

Factors Associated with Optimal Cosmetic Results at 36 Months in Patients Treated with Accelerated Partial Breast Irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial. Beitsch- Ann Surg Onc. 2009 Sep.

Friday, 01 April 2016 00:00

American Society of Breast Surgeons Mammosite radiation therapy system registry trial: ductal carcinoma-in-situ subset analysis – 4-year data in 194 treated lesions. Beitsch and Gittleman et al - Am J Surg. 2009 Oct

Friday, 01 April 2016 00:00

Special report: Concensus conference III. Image-detected breast cancer: state-of-the-art diagnosis and treatment. Whitworth et al - J Am Coll Surg. 2009 Oct.

Friday, 01 April 2016 00:00

Attaining Negative Margins in Breast-Conservation Operations: Is There a Consensus among Breast Surgeons? Beitsch et al - J Am Coll Surg. 2009 Nov.

Friday, 01 April 2016 00:00

Factors associated with false-negative sentinel lymph node biopsy in melanoma patients. Beitsch et al - Ann Surg Oncol. 2010 Mar.

Friday, 01 April 2016 00:00

Update on DCIS Outcomes from the American Society of Breast Surgeons Accelerated Partial Breast Irradiation Registry Trial. Beitsch et al - Ann Surg Oncol. 2010 Jun.

Friday, 01 April 2016 00:00

Adherence to the National Quality Forum (NOF) breast cancer measures within cancer clinical trials: a review from ACOSG Z0010. Whitworth et al - Ann Surg Oncol. 2010 Aug.

Friday, 01 April 2016 00:00

Locoregional Recurrence After Sentinel Lymph Node Dissection with or without Axillary Dissection in Patients with Sentinel Lymph Node Metastases: the American College of Surgeons Oncology Group Z0011 Randomized Trial. Beitsch and Whitworth. Ann Surg.

Friday, 01 April 2016 00:00

Five-year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the MammoSite Registry Trial.

Friday, 01 April 2016 00:00

Five-year outcome of patients classified in the “unsuitable” category using the American Society of Therapeutic Radiology and Oncology (ASTRO) concensus panel guidelines for the application of accelerated partial breast irradiation: an analysis. 2010

Friday, 01 April 2016 00:00

Controversies in Breast Surgery. Beitsch et al - Ann Surg Oncol. 2010 Oct.

Friday, 01 April 2016 00:00

Post-surgical treatment of early-stage breast cancer with electronic brachytherapy: an intersociety, multicenter brachytherapy trial. Beitsch et al - J OncoTargets and Therapy. 2010 Oct.

Friday, 01 April 2016 00:00

Ductal carcinoma in situ treated with breast-conserving surgery and accelerated partial breast irradiation: comparison of MammoSite registry trial with intergroup study E5194. Beitsch et al - Cancer. 2010 Nov.

Friday, 01 April 2016 00:00

Post-surgical treatment of early-stage breast cancer with electronic brachytherapy: outcomes and health-related quality of life at one year. Beitsch and Patel et al - Am J Clin Oncol. 2011.

Friday, 01 April 2016 00:00

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. Beitsch and Whitworth et al - JAMA. 2011 Feb.

Friday, 01 April 2016 00:00

Accelerated partial breast irradiation. Beitsch et al - J Surg Oncol. 2011 Mar.

Friday, 01 April 2016 00:00

Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Beitsch, Gittleman, and Whitworth. 2011.

Friday, 01 April 2016 00:00

A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes. Beitsch, Gittleman, and Whitworth et al - Cancer. 2011 Jun.

Friday, 01 April 2016 00:00

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. Whitworth and Beitsch et al - Cancer. 2011 Jun.

Friday, 01 April 2016 00:00

Advances in nipple-sparing mastectomy: oncological safety and incision selection. Whitworth et al - Aesthet Surg J. 2011 Mar.

Thursday, 31 March 2016 00:00

Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. Whitworth et al - JAMA. 2011 Jul.

Thursday, 31 March 2016 00:00

Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy. Patel et al - Radiother Oncol. 2011 Aug.

Thursday, 31 March 2016 00:00

Community Melanoma Research: From Start Up to Follow Up. Beitsch et al - J Surg Oncol. 2011 Sep.

Thursday, 31 March 2016 00:00

Breast conserving surgery and accelerated partial breast irradiation after prior breast radiation therapy. Patel et al - Int J Radiat Oncol Biol Phys. 2011 Sep.

Thursday, 31 March 2016 00:00

Outcomes after accelerated partial breast irradiation in patients with ASTRO consensus statement cautionary features. Patel et al - Int J Radiat Oncol Biol Phys. 2011 Sep.

Thursday, 31 March 2016 00:00

Intact Percutaneous Excision (IPEX) for Definitive Diagnosis of High-Risk Breat Lesions. Whitworth PW - Ann Surg Oncol. 2011 Oct.

Thursday, 31 March 2016 00:00

Definitive diagnosis for high-risk breast lesions without open surgical excision: the Intact Percutaneous Excision Trial (IPET). Whitworth et al - Ann Surg Onc. 2011 Oct.

Thursday, 31 March 2016 00:00

Predictors of local recurrence following accelerated partial breast irradiation: a pooled analysis. Beitsch et al - Int J Radiation Oncol. 2011 Nov.

Thursday, 31 March 2016 00:00

Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy. Beitsch - Int J of Radiation Oncol Bio Phys. 2011 Nov.

Thursday, 31 March 2016 00:00

Axillary failure in patients treated with MammoSite accelerated partial breast irradiation. Beitsch et al. -Ann Surg Oncol. 2011 Nov.

Thursday, 31 March 2016 00:00

Phase I Trial of “bi-shRNAi(furin)GMCSF DNA/Autologous Tumor Cell” vaccine (FANG) in advanced cancer. Beitsch et al - Mol Therapy: J of Am Soc Gene Therapy. 2011 Dec.

Thursday, 31 March 2016 00:00

ACOSOG Z0011 changing behavior: results of a survey of the american society of breast surgeons. Beitsch et al - Ann Surg Oncol. 2012.

Thursday, 31 March 2016 00:00

Patterns of failure after accelerated partial breast irradiation by consensus panel group: a pooled analysis of William Beaumont Hospital and the American Society of Breast Surgeons trial data. Beitsch et al - Am Soc Radiat Oncol. 2012.

Thursday, 31 March 2016 00:00

Phase I trial of pelvic nodal dose escalation with hypofractionated IMRT for high-risk prostate cancer. Patel et al - Int J Radiat Oncol Biol Phys. 2012 Jan.

Thursday, 31 March 2016 00:00

Outcome following ipsilateral breast tumor recurrence in patients treated with accelerated partial breast irradiation. Beitsch et al - Cancer. 2012 Jan

Thursday, 31 March 2016 00:00

Six-year analysis of treatment-related toxicities in patients treated with accelerated partial breast irradiation on the american society of breast surgeons Mammosite breast brachytherapy trial . Beitsch et al - Ann Surg Oncol. 2012.

Thursday, 31 March 2016 00:00

Local control, toxicity, and cosmesis in women >70 years enrolled in the American Society of Breast Surgeons accelerated partial breast irradiation registry trial. Whitworth and Gittleman et al - Int J Radiat Oncol Biol Phys. 2012 Feb.

Thursday, 31 March 2016 00:00

Bioelectrical impedance for detecting and monitoring patients for the development of upper limb lymphedema in the clinic. Whitworth et al - Clin Breast Cancer. 2012 Apr.

Thursday, 31 March 2016 00:00

Breast-cancer related lymphedema: a review of procedure-specific incidence rates, clinical assessment AIDS, treatment paradigms, and risk reductions. Whitworth et al - Breast J. 2012 Jul.

Thursday, 31 March 2016 00:00

Factors associated with local-regional recurrence after a negative sentinel node: results of the ACOSOG Z0010 trial. Whitworth et al - Ann Surg. 2012 Sept.

Thursday, 31 March 2016 00:00

Evaluation of current consensus panel guidelines for APBI: a pooled analysis of breast surgeons MammoSite registry trial data. Beitsch and Wilkinson - Int J Radiat Oncol Biol Phys. 2012 Oct.

Thursday, 31 March 2016 00:00

Tumor bed control with balloon-based accelerated partial breast irradiation: incidence of true recurrences vs. elsewhere failures in the American Society of Breast Surgery MammoSite Registry Trial. Beitsch and Whitworth - Ann Surg Onc. 2012

Thursday, 31 March 2016 00:00

Gene expression profiling to predict the risk of locoregional recurrence in breast cancer. Beitsch et al - Cancer Research. 2012 Dec.

Thursday, 31 March 2016 00:00

Prospective neo-adjuvant registry trial linking MammaPrint, subtyping and treatment response: Neoadjuvant Breast Registry- Symphony Trial (NBRST). Whitworth and Gittleman et al - Presentation at SABCS. 2012 Dec.

Thursday, 31 March 2016 00:00

Multi-institutional analysis of bioimpedance spectroscopy in the early detection of breast cancer related lymphedema. Beitsch and Whitworth et al - J Cancer Res Ther. 2013

Thursday, 31 March 2016 00:00

The use of bioimpedance spectroscopy to monitor response to treatment interventions with breast cancer-related lymphedema. Beitsch et al - Int J Radiat Oncol Biol Phys. 2013 Oct

Thursday, 31 March 2016 00:00

Long term follow up: phase I trial of “bi-shRNA furin/GMCSF DNA/autologous tumor cell” immunotherapy (FANG) in advanced cancer. Beitsch et al - J Vaccines and Vaccination. 2013 Oct.

Thursday, 31 March 2016 00:00

Chemosensitivity and endocrine sensitivity predicted by MammaPrint and BluePrint in the prospective Neoadjuvant Breast Registry Symphony Trial (NBRST). Whitworth and Gittleman et al - Presentation at SABCS. 2013 Dec.

Thursday, 31 March 2016 00:00

Concordance of microassay based determination of ER, PR, and HER2 receptor status and local IHC/FISH assessment in the prospective Neoadjuvant Breast Registry – Symphony Trial (NBRST). Beitsch and Gittleman et al - Presentation at SABCS. 2013 Dec.

Thursday, 31 March 2016 00:00

The Impact of Intraoperative Margin Assessment with Adjunctive Use of Marginprobe vs. Standard of Care, Dependence on Margin Threshold Definition. Gittleman et al - Presentation SABCS. 2013 Dec.

Thursday, 31 March 2016 00:00

Can breast surgeons provide breast cancer genetic testing? An American society of breast surgeons survey. Beitsch and Whitworth - Ann Surg Onc. 2014 Apr.

Thursday, 31 March 2016 00:00

A Randomized Prospective Study of Lumpectomy Margin Assessment with Use of MarginProbe in Patients with Nonpalpable Breast Malignancies. Gittleman et al - Ann Surg Oncol. 2014 May.

Thursday, 31 March 2016 00:00

Chemosensitivity and endocrine sensitivity predicted by mammaprint and blueprint in the neo-adjuvant breast registry symphony trial (NBRST). Whitworth and Gittleman et al - Presentation at ASCO. 2014 Jun.

Thursday, 31 March 2016 00:00

American Society of Breast Surgeons Presidential Address: Breast Cancer Surgery is Dead…or is it? Beitsch - Ann Surg Onc. 2014 Jul.

Thursday, 31 March 2016 00:00

Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the prospective neoadjuvant breast registry symphony trial (NBRST). Beitsch, Gittleman, and Whitworth et al - Ann Surg Onc. 2014 Aug.

Thursday, 31 March 2016 00:00

Functional Subtyping with BluePrint 80-gene profile identifies 2 distinct triple positive subtypes with and without trastuzumab/chemo-sensitivity: implications for treatment from NBRST registry. Beitsch, Gittleman, Whitworth - J Clin Oncol. 2015 Oct.

Thursday, 31 March 2016 00:00

Three distinct HER2 subtypes identified by BluePrint 80-gene functional subtyping predict treatment-specific response in the prospective neo-adjuvant NBRST registry. Gittleman and Whitworth et al - Presentation SABCS. 2015.

Thursday, 31 March 2016 00:00

1/3 of HER2 positive patients have 80-gene luminal subtype resistant to chemo-trastuzumab but sensitive to chemo-trastuzumab-pertuzumab: critical implications for adjuvant setting from NBRST phase 4 study. Beitsch- Presentation SABCS 2015.

Thursday, 31 March 2016 00:00

Pertuzumab overcomes chemotherapy/trastuzumab resistance in ER+/HER2+ tumors classified as Luminal functional subtype by 80-gene BluePrint assay in prospective neoadjuvant breast registry symphony trial. Beitsch Gittleman. Presentation SABCS. 2015.

Thursday, 31 March 2016 00:00

Chemosensitivity and endocrine sensitivity predicted by MammaPrint and BluePrint in clinical luminal patients in the prospective NBRST study. Gittleman et al - Presentation SABCS. 2015.

Thursday, 31 March 2016 00:00

Magnetic Nano Device for Identification of the breast sentinel node- a novel method. The SentimagIC Trial. Beitsch and Gittleman et al - Presentation SABCS. 2015.

Thursday, 31 March 2016 00:00

Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation. Beitsch et al - Int J Radiation Oncol Biol Phys. 2015 Feb.

Thursday, 31 March 2016 00:00

Device Outcomes and Impact Registry Platform

Wednesday, 06 April 2016 00:00

Beware of 'RUI": Radiating Under the Influence

Monday, 13 April 2015 00:00

savi scout

Tuesday, 23 December 2014 00:00

BluePrint, the 80 gene molecular subtyping assay

Tuesday, 23 December 2014 00:00

breast cancer seminar

Tuesday, 23 December 2014 00:00
Page 2 of 3